The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer
The definitive characterization of common cancer stem cell (CSCs) subpopulations in breast cancer subtypes with distinct genotypic and phenotypic features remains an ongoing challenge. In this study, we have used a non-biased genome wide screening approach to identify transcriptional networks that m...
Κύριοι συγγραφείς: | Walsh, CA, Akrap, N, Garre, E, Magnusson, Y, Harrison, H, Andersson, D, Jonasson, E, Rafnsdottir, S, Choudhry, H, Buffa, F, Ragoussis, J, Ståhlberg, A, Harris, A, Landberg, G |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Public Library of Science
2020
|
Παρόμοια τεκμήρια
-
The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.
ανά: Claire A Walsh, κ.ά.
Έκδοση: (2020-01-01) -
Induction of resistance to neurotrophic tropomyosin‐receptor kinase inhibitors by HMGCS2 via a mevalonate pathway
ανά: Yasuhiro Kato, κ.ά.
Έκδοση: (2024-06-01) -
Identification of Distinct Breast Cancer Stem Cell Populations Based on Single-Cell Analyses of Functionally Enriched Stem and Progenitor Pools
ανά: Nina Akrap, κ.ά.
Έκδοση: (2016-01-01) -
Proteomics of cell‐free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer‐progressing properties
ανά: Anna Gustafsson, κ.ά.
Έκδοση: (2024-06-01) -
Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion
ανά: Sara Rhost, κ.ά.
Έκδοση: (2018-11-01)